VLA 0.00% $1.75 viralytics limited

phase ii trial, page-2

  1. 925 Posts.
    Hi Kato,

    They have recruited 9 or 10 patients to the trial, however as it involves multiple doses over a number of weeks, only one patient has completed the full trial (while still waiting for the six month follow up).

    Given this, nobody is going to rant or rave about Cavatak yet even if this one patients tumor was complete destroyed, due to the fact that it is only one patient out of a 60+ patient trial.

    I would expect to hear some progress once ten or so patients have completed the multiple doses.

    Hope this helps,

    Skhammer
 
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.